Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1979 1
1980 3
1982 2
1983 2
1984 3
1985 1
1986 6
1988 1
1990 3
1991 3
1992 4
1993 3
1994 8
1995 6
1996 6
1997 9
1998 7
1999 8
2000 9
2001 10
2002 11
2003 9
2004 12
2005 8
2006 6
2007 4
2008 9
2009 7
2010 9
2011 16
2012 13
2013 14
2014 12
2015 9
2016 12
2017 16
2018 10
2019 12
2020 13
2021 19
2022 20
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
Pseudohypoaldosteronism.
Riepe FG. Riepe FG. Endocr Dev. 2013;24:86-95. doi: 10.1159/000342508. Epub 2013 Feb 1. Endocr Dev. 2013. PMID: 23392097 Review.
Pseudohypoaldosteronism (PHA) is a rare syndrome of mineralocorticoid resistance. ...
Pseudohypoaldosteronism (PHA) is a rare syndrome of mineralocorticoid resistance. ...
Mineralocorticoid resistance.
Zennaro MC, Lombès M. Zennaro MC, et al. Trends Endocrinol Metab. 2004 Aug;15(6):264-70. doi: 10.1016/j.tem.2004.06.003. Trends Endocrinol Metab. 2004. PMID: 15358279 Review.
Mineralocorticoid resistance, also known as type I pseudohypoaldosteronism (PHA1), is a rare inherited disease characterized by salt wasting, dehydration and failure to thrive in the newborn. ...
Mineralocorticoid resistance, also known as type I pseudohypoaldosteronism (PHA1), is a rare inherited disease characterized by salt …
Difficulties in the diagnosis and management of eight infants with secondary pseudohypoaldosteronism.
Günay F, Şıklar Z, Berberoğlu M. Günay F, et al. Turk J Pediatr. 2022;64(3):490-499. doi: 10.24953/turkjped.2021.1443. Turk J Pediatr. 2022. PMID: 35899562 Free article.
BACKGROUND: Type 1 pseudohypoaldosteronism (PHA1) is a rare condition characterized by the resistance of the kidney to the effect of aldosterone. ...
BACKGROUND: Type 1 pseudohypoaldosteronism (PHA1) is a rare condition characterized by the resistance of the kidney to the effect of …
WNK1 in the kidney.
Bahena-Lopez JP, Gamba G, Castañeda-Bueno M. Bahena-Lopez JP, et al. Curr Opin Nephrol Hypertens. 2022 Sep 1;31(5):471-478. doi: 10.1097/MNH.0000000000000820. Epub 2022 Jul 15. Curr Opin Nephrol Hypertens. 2022. PMID: 35894282 Review.
Diagnostic approach to low-renin hypertension.
Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P. Monticone S, et al. Clin Endocrinol (Oxf). 2018 Oct;89(4):385-396. doi: 10.1111/cen.13741. Epub 2018 Jun 6. Clin Endocrinol (Oxf). 2018. PMID: 29758100 Review.
The WNK signaling pathway and salt-sensitive hypertension.
Furusho T, Uchida S, Sohara E. Furusho T, et al. Hypertens Res. 2020 Aug;43(8):733-743. doi: 10.1038/s41440-020-0437-x. Epub 2020 Apr 14. Hypertens Res. 2020. PMID: 32286498 Review.
The distal nephron of the kidney has a central role in sodium and fluid homeostasis, and disruption of this homeostasis due to mutations of with-no-lysine kinase 1 (WNK1), WNK4, Kelch-like 3 (KLHL3), or Cullin 3 (CUL3) causes pseudohypoaldosteronism type II (PHAII), an inh …
The distal nephron of the kidney has a central role in sodium and fluid homeostasis, and disruption of this homeostasis due to mutations of …
Pseudohypoaldosteronism.
Dillon MJ, Leonard JV, Buckler JM, Ogilvie D, Lillystone D, Honour JW, Shackleton CH. Dillon MJ, et al. Arch Dis Child. 1980 Jun;55(6):427-34. doi: 10.1136/adc.55.6.427. Arch Dis Child. 1980. PMID: 7002056 Free PMC article.
10 infants are described with pseudohypoaldosteronism, 5 in detail and a further 5 briefly. They all presented with hyperkalaemia, urinary salt-wasting disease, and ostensibly normal renal and adrenocortical function. ...The precise aetiology of the condition remains conje …
10 infants are described with pseudohypoaldosteronism, 5 in detail and a further 5 briefly. They all presented with hyperkalaemia, ur …
Hyper- and hypoaldosteronism.
Torpy DJ, Stratakis CA, Chrousos GP. Torpy DJ, et al. Vitam Horm. 1999;57:177-216. doi: 10.1016/s0083-6729(08)60644-5. Vitam Horm. 1999. PMID: 10232050 Review.
Hypoaldosteronism may be due to inadequate stimulation of aldosterone secretion (hyporeninemic hypoaldosteronism), defects in adrenal synthesis of aldosterone, or resistance to the ion transport effects of aldosterone, such as are seen in pseudohypoaldosteronism type I (PH …
Hypoaldosteronism may be due to inadequate stimulation of aldosterone secretion (hyporeninemic hypoaldosteronism), defects in adrenal synthe …
Clinical and Molecular Perspectives of Monogenic Hypertension.
Levanovich PE, Diaczok A, Rossi NF. Levanovich PE, et al. Curr Hypertens Rev. 2020;16(2):91-107. doi: 10.2174/1573402115666190409115330. Curr Hypertens Rev. 2020. PMID: 30963979 Free PMC article. Review.
Geller syndrome is due to a point mutation in the hormone responsive element of the promotor for the mineralocorticoid receptor, rendering the receptor susceptible to activation by progesterone, leading to hypertension during pregnancy. Pseudohypoaldosteronism type II (PHA …
Geller syndrome is due to a point mutation in the hormone responsive element of the promotor for the mineralocorticoid receptor, rendering t …
318 results